Feng Zheng

Dr. Feng Zheng


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
MSMangmang Sang
Mangmang Sang
LHLingfei Han
Lingfei Han
RLRenjie Luo
Renjie Luo
WQWei Qu
Wei Qu
FZFeng Zheng
Feng Zheng
FFFeng Feng
Feng Feng
Gambogic acid (GA) is a natural anti-tumor drug whose application is restricted by its poor aqueous solubility and inefficient bioavailability. Developing nanomaterials with excellent biocompatibility can amplify the therapeutic effects of GA. In this study, a tumor-targeted redox controllable self-assembled nano-system with magnetic enhanced EPR effects (mPEG-HA/CSO-SS-Hex/SPION/GA) was developed to improve the anticancer efficacy of GA. The nano-system is constituted by three layers: the outer layer is mono-aminated poly(ethylene glycol) grafted hyaluronic acid (mPEG-HA), which can target the CD44 receptor in breast cancer cells; the middle layer consists of disulfide linked hexadecanol (Hex) and chitosan oligosaccharide (CSO) to control the drug release by reduction response; the core layer is superparamagnetic iron oxide nanoparticles (SPION), which can enhance the EPR effect by magnetic guidance and contribute to GA entrapment. Different experiments were performed to characterize the complex self-assembly, and the cytotoxicity, pharmacokinetics, and in vivo antitumor activity of the self-assembly were investigated to evaluate its anti-tumor effects. The results revealed that mPEG-HA/CSO-SS-Hex/SPION/GA is an excellent nanosystem with appropriate size and sensitive responsiveness; it can accumulate in tumor sites and achieve excellent therapeutic effects on triple-negative breast cancer (TNBC). In summary, a CD44-targeted redox-triggered self-assembly nanosystem with magnetic enhanced EPR effects was developed for effective amplification of GA; it has potential to act as an effective carrier in drug delivery for chemotherapy of TNBC.

1 January 2018 in Drug Delivery
Verified
Journal Article
Open access
MSMang Mang Sang
Mang Mang Sang
FLFu Lei Liu
Fu Lei Liu
YWYang Wang
Yang Wang
RLRen Jie Luo
Ren Jie Luo
XHXiao Xian Huan
Xiao Xian Huan
FZFeng Zheng
Feng Zheng
Gambogic acid (GA) is a naturally derived potent anticancer agent with extremely poor biocompatibility. In the present study, a novel of redox/pH dual-responsive multifunctional magnetic complex micelle (sPEG/HA/CSO-SS-Hex/Fe3O4/GA), which consisted of a reducible hexadecanol-modified chitosan oligosaccharide polymer micelle (CSO-SS-Hex) coated with hyaluronic acid (HA) and DCA grafted sheddable PEG-PLL (sPEG) copolymers and loaded with gambogic acid (GA) and Fe3O4 nanoparticles were developed for parenteral delivery for the treatment of triple negative breast cancer (TNBC). The ex vivo study showed that the sPEG shielded cationic HA/CSO-SS-Hex/Fe3O4/GA core at physiological pH but quickly shed off to re-expose the core due to its charge reversible property. The sPEG/HA/CSO-SS-Hex/Fe3O4/GA micelles effectively facilitated tumor-targeted GA delivery by HA, which is a targeting ligand for CD44 receptor of TNBC cells, meanwhile increase GA uptake at the acidic condition but diminished the drug uptake at neutral pH. The in vitro cellular uptake study and in vivo biodistribution and antitumor activity of the formulations were determined, all results showed that the complex micelle enhanced TNBC tumor cellular uptake and fast drug release due to the combined effect of magnet targeting, CD44 receptor-mediated internalization and redox/pH dual-responsive drug release. Hence, tumor-targeted delivery of GA with redox/pH dual-responsive multifunctional magnetic complex micelle sPEG/HA/CSO-SS-Hex/Fe3O4/GA might have potential implications for the chemotherapy of TNBC.

1 August 2014 in Journal of Chromatography A
Verified
Journal Article
Closed access
TGTian Guo
Tian Guo
YSYuanyuan Shi
Yuanyuan Shi
LZLi Zheng
Li Zheng
FFFeng Feng
Feng Feng
FZFeng Zheng
Feng Zheng
WLwenyuan liu
wenyuan liu

1 July 2018 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
LLLan Luo
Lan Luo
CGCongcong Gu
Congcong Gu
MLMingxian Li
Mingxian Li
XZXiangyuan Zheng
Xiangyuan Zheng
FZFeng Zheng
Feng Zheng

1 January 2012 in Analytical Biochemistry
Verified
Journal Article
Closed access
FZFeng Zheng
Feng Zheng
ZWZheng Wu
Zheng Wu
YCYihua Chen
Yihua Chen

1 April 2019 in Journal of Chromatography A
Verified
Journal Article
Closed access
MLMingxian Li
Mingxian Li
CGCongcong Gu
Congcong Gu
LLLan Luo
Lan Luo
JZJie Zhou
Jie Zhou
JLJing Liu
Jing Liu
FZFeng Zheng
Feng Zheng